Overexpression of suppressor of cytokine signaling-3 in T cells exacerbates acetaminophen-induced hepatotoxicity

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3777-3785

  Numata, Kosuke ^a   Kubo, Masato ^b   Watanabe, Hiroyuki ^a   Takagi, Katsumasa ^a   Mizuta, Hiroshi ^a   Okada, Seiji ^c   Kunkel, Steven L ^d   Ito, Takaaki ^a   Matsukawa, Akihiro ^a,e  

^a KUMAMOTO UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NEUTRALIZING ANTIBODY; PARACETAMOL; PROTEIN BNIP3; REGULATOR PROTEIN; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MODEL; DRUG INDUCED DISEASE; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENE; TRANSGENIC MOUSE;

EID: 33947245418     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3777     Document Type: Article

References (49)

1. Whitcomb, D. C. 1994. Acetaminophen poisoning and liver function. N. Engl. J. Med. 331: 1311-1312.
2. Jaeschke, H., and M. L. Bajt. 2006. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol. Sci. 89: 31-41.
3. James, L. P., P. R. Mayeux, and J. A. Hinson. 2003. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31: 1499-1506.
4. Blazka, M. E., J. L. Wilmer, S. D. Holladay, R. E. Wilson, and M. I. Luster. 1995. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 133: 43-52.
5. Jaeschke, H. 2005. Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 1: 389-397.
6. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662.
7. Matsukawa, A., M. H. Kaplan, C. M. Hogaboam, N. W. Lukacs, and S. L. Kunkel. 2001. Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J. Exp. Med. 193: 679-688.
8. Matsukawa, A., S. Kudo, T. Maeda, K. Numata, H. Watanabe, K. Takeda, S. Akira, and T. Ito. 2005. Stat3 in resident macrophages as a repressor protein of inflammatory response. J. Immunol. 175: 3354-3359.
9. Matsukawa, A., K. Takeda, S. Kudo, T. Maeda, M. Kagayama, and S. Akira. 2003. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J. Immunol. 171: 6198-6205.
10. Gao, B. 2005. Cytokines, STATs and liver disease. Cell Mol. Immunol. 2: 92-100.
11. Hong, F., B. Jaruga, W. H. Kim, S. Radaeva, O. N. El-Assal, Z. Tian, V. A. Nguyen, and B. Gao. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J. Clin. Invest. 110: 1503-1513.
12. Kim, W. H., F. Hong, S. Radaeva, B. Jaruga, S. Fan, and B. Gao. 2003. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G761-G768.
13. Li, W., X. Liang, C. Kellendonk, V. Poli, and R. Taub. 2002. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J. Biol. Chem. 277: 28411-28417.
14. Klein, C., T. Wustefeld, U. Assmus, T. Roskams, S. Rose-John, M. Muller, M. P. Manns, M. Ernst, and C. Trautwein. 2005. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. J. Clin. Invest. 115: 860-869.
15. Ishida, Y., T. Kondo, T. Ohshima, H. Fujiwara, Y. Iwakura, and N. Mukaida. 2002. A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 16: 1227-1236.
16. Alexander, W. S., and D. J. Hilton. 2004. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22: 503-529.
17. Gatto, L., C. Berlato, V. Poli, S. Tininini, I. Kinjyo, A. Yoshimura, M. A. Cassatella, and F. Bazzoni. 2004. Analysis of SOCS-3 promoter responses to interferon γ. J. Biol. Chem. 279: 13746-13754.
18. Sasaki, A., H. Yasukawa, A. Suzuki, S. Kamizono, T. Syoda, I. Kinjyo, M. Sasaki, J. A. Johnston, and A. Yoshimura. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4: 339-351.
19. Seki, Y., H. Inoue, N. Nagata, K. Hayashi, S. Fukuyama, K. Matsumoto, O. Komine, S. Hamano, K. Himeno, K. Inagaki-Ohara, et al. 2003. SOCS-3 regulates onset and maintenance of Th2-mediated allergic responses. Nat. Med. 9: 1047-1054.
20. Hogaboam, C. M., C. L. Bone-Larson, M. L. Steinhauser, A. Matsukawa, J. Gosling, L. Boring, I. F. Charo, K. J. Simpson, N. W. Lukacs, and S. L. Kunkel. 2000. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am. J. Pathol. 156: 1245-1252.
21. Liu, Z. X., S. Govindarajan, and N. Kaplowitz. 2004. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127: 1760-1774.
22. Liu, Z. X., D. Han, B. Gunawan, and N. Kaplowitz. 2006. Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43: 1220-1230.
23. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, H. L. Evanoff, R. M. Strieter, and S. L. Kunkel. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164: 2738-2744.
24. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
25. Thorburn, A. 2004. Death receptor-induced cell killing. Cell Signal 16: 139-144.
26. Morgan, D. O. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13: 261-291.
27. Pestell, R. G., C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold. 1999. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20: 501-534.
28. Schlossberg, H., Y. Zhang, L. Dudus, and J. F. Engelhardt. 1996. Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. Hepatology 23: 1546-1555.
29. Antoniades, C. G., P. A. Berry, E. T. Davies, M. Hussain, W. Bernal, D. Vergani, and J. Wendon. 2006. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34-43.
30. Guo, D., J. D. Dunbar, C. H. Yang, L. M. Pfeffer, and D. B. Donner. 1998. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J. Immunol. 160: 2742-2750.
31. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
32. Jaruga, B., F. Hong, W. H. Kim, and B. Gao. 2004. IFN-γ/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1044-G1052.
33. Kumar, A., M. Commane, T. W. Flickinger, C. M. Horvath, and G. R. Stark. 1997. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278: 1630-1632.
34. x promoters. Cell Death Differ. 7: 329-330.
35. Ivanov, V. N., A. Bhoumik, M. Krasilnikov, R. Raz, L. B. Owen-Schaub, D. Levy, C. M. Horvath, and Z. Ronai. 2001. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol. Cell 7: 517-528.
36. Cressman, D. E., R. H. Diamond, and R. Taub. 1995. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 21: 1443-1449.
37. Suzuki, A., T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471-481.
38. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159: 1418-1428.
39. Chiu, H., C. R. Gardner, D. M. Dambach, S. K. Durham, J. A. Brittingham, J. D. Laskin, and D. L. Laskin. 2003. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol. Appl. Pharmacol. 193: 218-227.
40. Qing, Y., and G. R. Stark. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-γ. J. Biol. Chem. 279: 41679-41685.
41. Ogata, H., T. Kobayashi, T. Chinen, H. Takaki, T. Sanada, Y. Minoda, K. Koga, G. Takaesu, Y. Maehara, M. Iida, and A. Yoshimura. 2006. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131: 179-193.
42. Egwuagu, C. E., C. R. Yu, M. Zhang, R. M. Mahdi, S. J. Kim, and I. Gery. 2002. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168: 3181-3187.
43. Ozaki, A., Y. Seki, A. Fukushima, and M. Kubo. 2005. The control of allergic conjunctivitis by suppressor of cytokine signaling (SOCS)3 and SOCS5 in a murine model. J. Immunol. 175: 5489-5497.
44. Jo, D., D. Liu, S. Yao, R. D. Collins, and J. Hawiger. 2005. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat. Med. 11: 892-898.
45. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity 4: 471-481.
46. Philip, R., and L. B. Epstein. 1986. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 323: 86-89.
47. Yu, C. R., R. M. Mahdi, S. Ebong, B. P. Vistica, I. Gery, and C. E. Egwuagu. 2003. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J. Biol. Chem. 278: 29752-29759.
48. Chen, Z., A. Laurence, Y. Kanno, M. Pacher-Zavisin, B. M. Zhu, C. Tato, A. Yoshimura, L. Hennighausen, and J. J. O'Shea. 2006. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103: 8137-8142.
49. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.